Should You Buy First Wave BioPharma Inc (FWBI) Stock Thursday?

First Wave BioPharma Inc (FWBI) stock has fallen -94.35% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives FWBI stock a score of 33 out of a possible 100.

That rank is mainly influenced by a long-term technical score of 2. FWBI's rank also includes a short-term technical score of 3.

FWBI has an Overall Score of 33. Find out what this means to you and get the rest of the rankings on FWBI!

See Full FWBI Report

What's Happening with FWBI Stock Today

First Wave BioPharma Inc (FWBI) stock has risen 130.15% while the S&P 500 is higher by 0.47% as of 9:34 AM on Thursday, Sep 14. FWBI is higher by $0.57 from the previous closing price of $0.44 on volume of 25,645,287 shares. Over the past year the S&P 500 is higher by 13.75% while FWBI has fallen -94.35%. FWBI earned $8.97 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 0.11. Click Here to get the full Stock Report for First Wave BioPharma Inc stock.